HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andreasen, P. A. Articles by Dano, K. Search for Related Content PubMed PubMed Citation Articles by Andreasen, P. A. Articles by Dano, K. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 17, 7644-7651, Jun, 1986

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

PA Andreasen, LS Nielsen, P Kristensen, J Grondahl-Hansen, L Skriver and K Dano

An approximately 75% pure form of a human Mr approximately 54,000 plasminogen activator inhibitor from conditioned culture fluid of the fibrosarcoma cell line HT-1080 was obtained by a single step of chromatography on concanavalin A-Sepharose. The inhibitor inhibited human urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator, but not plasmin. Rabbit antibodies against this plasminogen activator inhibitor also reacted with a plasminogen activator inhibitor with identical electrophoretic mobility in extracts of human blood platelets, indicating that the HT-1080-inhibitor is of the same type as the inhibitor of blood platelets. As revealed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by fibrin-agarose zymography, incubation of HT-1080-inhibitor with the active form of human u-PA led to the formation of an equimolar sodium dodecyl sulfate-resistant complex between them; in contrast, no complex formation was observed between the inhibitor and the proenzyme form of human u-PA (pro-u-PA). Likewise, using a column of anti-inhibitor antibodies coupled to Sepharose for removal of excess inhibitor and activator-inhibitor complexes, the potential enzymatic activity of pro- u-PA was found to be unaffected by incubation with inhibitor under conditions in which more than 95% of the active u-PA had formed complex with inhibitor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Verheyden, A. Sillen, A. Gils, P. J. Declerck, and Y. Engelborghs Tryptophan Properties in Fluorescence and Functional Stability of Plasminogen Activator Inhibitor 1 Biophys. J., July 1, 2003; 85(1): 501 - 510. [Abstract] [Full Text] [PDF]

				A. N. Pedersen, I. J. Christensen, R. W. Stephens, P. Briand, H. T. Mouridsen, K. Danø, and N. Brünner; The Complex between Urokinase and Its Type-1 Inhibitor in Primary Breast Cancer: Relation to Survival Cancer Res., December 1, 2000; 60(24): 6927 - 6934. [Abstract] [Full Text]

				E. Dublin, A. Hanby, N. K. Patel, R. Liebman, and D. Barnes Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma : Fibroblastic Expression Has Strong Associations with Tumor Pathology Am. J. Pathol., October 1, 2000; 157(4): 1219 - 1227. [Abstract] [Full Text] [PDF]

				L. B. Johnsen, K. Poulsen, M. Kilian, and T. E. Petersen Purification and Cloning of a Streptokinase from Streptococcus uberis Infect. Immun., March 1, 1999; 67(3): 1072 - 1078. [Abstract] [Full Text] [PDF]

				P. Franco, O. Massa, M. Garcia-Rocha, F. Chiaradonna, C. Iaccarino, I. Correas, E. Mendez, J. Avila, F. Blasi, and M. P. Stoppelli Protein Kinase C-dependent in Vivo Phosphorylation of Prourokinase Leads to the Formation of a Receptor Competitive Antagonist J. Biol. Chem., October 16, 1998; 273(42): 27734 - 27740. [Abstract] [Full Text] [PDF]

				L. Zhang, D. K. Strickland, D. B. Cines, and A. A.-R. Higazi Regulation of Single Chain Urokinase Binding, Internalization, and Degradation by a Plasminogen Activator Inhibitor 1-Derived Peptide J. Biol. Chem., October 24, 1997; 272(43): 27053 - 27057. [Abstract] [Full Text] [PDF]

				V. Ellis and V. Ellis Functional Analysis of the Cellular Receptor for Urokinase in Plasminogen Activation. RECEPTOR BINDING HAS NO INFLUENCE ON THE ZYMOGENIC NATURE OF PRO-UROKINASE J. Biol. Chem., June 21, 1996; 271(25): 14779 - 14784. [Abstract] [Full Text] [PDF]

				W. L. Chandler, W. C. Levy, and J. R. Stratton The Circulatory Regulation of TPA and UPA Secretion, Clearance, and Inhibition During Exercise and During the Infusion of Isoproterenol and Phenylephrine Circulation, November 15, 1995; 92(10): 2984 - 2994. [Abstract] [Full Text]